Search NASA⌕ Search

SEARCH · Search NASA

Results for “YTTRIUM 82”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

6 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2019

Nuclear Data Sheets for A=82☆

The evaluators present in this publication spectroscopic data and level schemes from radioactive decay and nuclear reactions studies for all isobars, Z=28(Ni) to Z=42(Mo), with mass number A=82. For {sup 82}Ni not much is known other than its identification. Most of the new data, i.e., after the last NDS (2003Tu03), are based on compilations included in XUNDL. Contributions of the various compilers in XUNDL are gratefully acknowledged.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗
NASA NTRS1984

Hot-pressed silicon nitride with various lanthanide oxides as sintering additives

The effects of addition of various lanthanide oxides and their mixture with Y2O3 on the sintering of Si3N4 were investigated. The addition of simple and mixed lanthanide oxides promoted the densification of Si3N4 in hot-pressing at 1800 C under 300-400kg/ centimeters squared for 60 min. The crystallization of yttrium and lanthanide-silicon oxynitrides which was observed inn the sintered body containing yttrium-lanthanide mixed oxides as additives led to the formation of a highly refractory Si3N4 ceramic having a bending strength of 82 and 84 kg/millimeters squared at room temperature and 1300 C respectively. In a Y2O3+La2O3 system, a higher molar ratio of La2O3 to Y2O3 gave a higher hardness and strength at high temperatures. It was found that 90 min was an optimum sintering time for the highest strength.

Ueno, K.↗
DOE OSTI2018

Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization

PurposeTo compare the use of cone-beam computed tomography versus contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the calculation of liver volume and planned dose for yttrium-90 radioembolization.Materials and MethodsThe study retrospectively assessed 47 consecutive patients who underwent resin Y-90 radioembolization consecutively over a 2-year period at a single center. Volume calculation software was used to determine perfused lobar liver volumes from cone-beam CT (CBCT) images obtained during mapping angiography. CBCT-derived volumes were compared with perfused lobar volume derived from contrast-enhanced CT and MRI. Nominal activities as determined by the SIR-Spheres Microspheres Activity Calculator were similarly calculated and compared using both CBCT and conventionally acquired volumes.ResultsA total of 82 hepatic lobes were assessed in 47 patients. The mean percentage difference between combined CT-MRI- and CBCT-derived calculated lobar volumes was 25.3% (p = 0.994). The mean percentage difference in calculated dose between the two methods was 21.8 ± 24.6% (p = 0.42). Combined left and right lobar CT-derived dose difference was less than 10% in 22 lobes, between 10 and 25% in 20 lobes, between 25 and 50% in 13 lobes and greater than 50% in 5 lobes. Combined left and right lobar MRI-derived dose difference was less than 10% in 11 lobes, between 10 and 25% in 7 lobes, between 25 and 50% in 2 lobes and greater than 50% in 1 lobe.ConclusionsAlthough volume measurements derived from CT/MRI did not differ significantly from those derived from CBCT, variability between the two methods led to large and unexpected differences in calculated dose.

62 RADIOLOGY AND NUCLEAR MEDICINE↗
DOE OSTI2017

Effect of CdTe Addition on the Electrical Properties and AC Susceptibility of YBa{sub 2}Cu{sub 3}O{sub 7−δ} Superconductor

The effect of CdTe addition on YBa{sub 2}Cu{sub 3}O{sub 7−δ}(CdTe){sub x} (x = 0–0.10) has been studied. XRD patterns showed the presence of impurities including CdTe for x ≥ 0.05 wt%. The resistance versus temperature curves showed metallic behavior for all samples. The onset temperature T{sub c onset} for all samples is between 90 and 92 K. The superconducting transition width, ΔT{sub c} = 4 K for all samples except for x = 0.1 wt% where ΔT{sub c} = 6 K. The superconducting transition determined by AC susceptibility measurement also showed little change in T{sub cχ{sup ′}} (between 89 and 92 K). However, the peak temperature T{sub p} of the imaginary part of the susceptibility χ″, showed a drastic decrease for samples with x > 0.05 wt%. This indicated that the superconducting grains were strongly decoupled for x > 0.05 wt% due to the impurities as observed in the XRD pattern. The intergrain critical current density, J{sub c} at T{sub p} for the x = 0 sample is J{sub c} (82 K) = 17 A cm{sup −2}. These results can be useful in the fabrication of semiconductor/YBCO superconductor hybrid systems.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗
DOE OSTI2018

AC Susceptibility and Superconducting Properties of Graphene Added YBa{sub 2}Cu{sub 3}O{sub 7−d}

The effect of graphene (G) addition on YBa{sub 2}Cu{sub 3}O{sub 7−δ}(G){sub x} (x = 0 − 0.03 wt%) has been studied using the X-ray diffraction method, scanning electron microscopy, electrical resistance versus temperature, transport critical current density J{sub c}, and AC susceptibility measurements. XRD patterns showed single-phase YBa{sub 2}Cu{sub 3}O{sub 7−δ} (YBCO) for all samples. SEM micrographs showed filling of the voids between YBa{sub 2}Cu{sub 3}O{sub 7−δ} grains as graphene was added. The temperature-dependent electrical resistance curves showed metallic normal state behavior and onset transition temperature T{sub conset} between 90 and 92 K for all samples. AC susceptibility measurement showed transition temperature T{sub cχ{sup ′}} between 90 and 93 K. T{sub cχ{sup ′}} was maintained or improved slightly as graphene was added. The x = 0.001 wt% showed the highest J{sub c}, i.e., 2750 A cm{sup −2} at 77 K and 5570 mA cm{sup −2} at 30 K which was 13 and 40 times higher than that of the non-added YBCO, respectively. The peak temperature T{sub p} of the imaginary part of the susceptibility χ{sup ″} was around 78–82 K for all samples indicating grain coupling was not weakened as graphene was added.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗
DOE OSTI2018

Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study

BackgroundRadioembolization induced liver disease (REILD) is a possible sequela of transarterial radioembolization (TARE), particularly in cases of whole-liver treatment. To mitigate this problem, the safety and efficacy of combined transarterial chemoembolization (TACE) and TARE were evaluated for patients with bilobar hepatocellular carcinoma (HCC).Materials and MethodsNineteen patients (mean age 60 years; range 27–82 years) treated for HCC between June 2012 and September 2014 were included in the analysis. Each patient was treated with combined TARE and TACE for bilobar HCC, with or without portal vein thrombosis. The hepatic lobe with large HCC was treated with TARE, and the other lobe with small HCC(s) was treated with TACE. Laboratory and clinical data were investigated to determine REILD occurrence. Survival data were analyzed to compare the treatment efficacy of alternative treatment modalities, including TACE and sequential TARE.ResultsAll patients underwent TARE for a dominant tumor in one lobe and TACE for small nodule(s) in the other lobe of the liver. The mean yttrium-90 microspheres used in TARE were 2.8 GBq (range; 1.0-3.5 GBq), and the mean doses of doxorubicin and iodized oil were 24.5 mg and 5.2 mL, respectively, for TACE. No statistical differences were noted between laboratory data measured before and after treatment, and no procedure-related major clinical complications occurred. The median time-to-progression of patients was 10.0 months, and the median overall survival was 27.3 months.ConclusionCombined radioembolization and chemoembolization appears to be a safe and effective treatment modality for bilobar HCC.

62 RADIOLOGY AND NUCLEAR MEDICINE↗